RMD News and Press, ResMed Inc. From 02/04/24

2024-02-04 06:14:22 ET Summary A weekly summary of dividend activity for Dividend Champions, Contenders, and Challengers. Companies which changed their dividends. Companies with upcoming ex-dividend dates. Companies with upcoming pay dates. Introduction The D...

2024-02-02 09:30:00 ET Summary MoneyShow presents top investment ideas for 2024 from their contributors. This year’s edition presents a broad mix of conservative income stocks, more speculative but potentially more rewarding growth stocks, as well as ETF recommendations tha...

2024-01-29 12:49:51 ET More on ResMed ResMed Inc. (RMD) Q2 2024 Earnings Call Transcript ResMed Inc. 2024 Q2 - Results - Earnings Call Presentation Why ResMed Is One Of My Top Picks In 2024 ResMed jumps 9% as quarterly results shine ResMed Q2 2024 Ear...

2024-01-27 04:24:00 ET Stock Traders Daily has produced this trading report using a proprietary method.  This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...

2024-01-26 13:17:16 ET More on Vera Therapeutics Vera Therapeutics: Soaring On IgAN Data, But Full Approval A Distant Prospect Vera hits 52-week high after long-term data for lead asset (update) Vera gains as Jefferies upgrades to Buy on lead asset Seeking Al...

2024-01-25 12:51:33 ET More on Axsome Therapeutics Axsome: Show Me Another Company With Such A Stack Of Catalysts Axsome Therapeutics: Positive Q3, We Like The Launch Success Story Axsome Therapeutics: Costs Outpacing Auvelity Growth (Rating Downgrade) New AD...

2024-01-25 12:07:03 ET Shares of ResMed (NYSE: RMD) were jumping 7% as of 11:25 a.m. ET on Thursday after rising as much as 10.6% earlier in the morning. The solid gain came after the medical device maker announced results for its fiscal 2024 second quarter ended Dec. 31, 2023, foll...

2024-01-25 06:01:52 ET ResMed Inc. has experienced positive revenue growth over the past three years, driven by increased demand and unit sales of devices and masks in the Sleep and Respiratory Care business and other markets. Operating expenses have evolved, and a restructuring plan has been...

2024-01-24 22:56:04 ET ResMed Inc. (RMD) Q2 2024 Earnings Conference Call January 24, 2024 04:30 PM ET Company Participants Amy Wakeham - Chief Communications and Investor Relations Officer Michael Farrell - Chief Executive Officer Brett Sandercock - Chief Financ...

2024-01-24 20:45:03 ET More on ResMed Why ResMed Is One Of My Top Picks In 2024 ResMed: Putting GLP-1 Myths To Sleep ResMed Q2 2024 Earnings Preview ResMed product recall classified as most serious by FDA (update) Read the full article on Seeking Al...